Newly-merged Ardena buys Dutch bio lab
Recently-formed CDMO Ardena has purchased bioanalytical contract laboratory ABL in Assen, the Netherlands.
Archives for September 25, 2017
Merck KGaA’s varied track & trace approach: 'We cannot rely on a singular security feature'
Merck KGaA says using a variety of tracking and authentication technologies and engaging with patients are vital to creating secure supply chains.
Red light for blue oxy: US FDA rejects Rexista's anti-abuse traits
The US FDA has rejected Intellipharmaceutics’ oxycodone product Rexista, raising concerns about the efficacy of its anti-abuse measures.
update
Pfizer confirms Puerto Rico plants damaged by hurricane Maria
Communication difficulties are hampering drug industry efforts to assess damage to manufacturing operations caused by the hurricane that struck Puerto Rico last week.
Barriers to outsourcing R&D: challenges are widely felt, says report
There are several barriers to outsourcing research and development (R&D) services, according to a recent survey of biotech and pharma leaders.
EMA says moving as a result of Brexit will delay approvals and slow public health efforts
Post-Brexit relocation will, at best, delay approvals and, at worst, limit drug availability and put European patients at greater risk of side effects and death according to the EMA.